Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
JW Therapeutics Announces Updated 1-year Follow-up Result of Relmacabtagene Autoleucel Injection At the 24th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) 2021-09-26 20:00
New Drug Application for Cadonilimab (PD-1/CTLA-4 Bi-Specific Antibody) for the Treatment of Relapsed or Metastatic Cervical Cancer Accepted by NMPA 2021-09-24 14:09
Everest Medicines Announces Approval of Investigational New Drug Application by China NMPA for SPR206 2021-09-24 13:56
Innovent Announces First Patient Dosed in a Phase 2 Clinical Trial of IBI112 (IL-23 Monoclonal Antibody) in Patients with Moderate-to-severe Plaque Psoriasis 2021-09-24 08:00
Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine 2021-09-23 21:59
BioVaxys Prepares for Groundbreaking Study on reduced ACE2 binding capabilities of Hapten-modified SARS-CoV-2 proteins 2021-09-23 15:00
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with Chemotherapy as First-Line Therapy for Esophageal Squamous Cell Carcinoma (ESCC) 2021-09-23 08:00
MedAlliance announces completion of enrollment in Japanese SELUTION SLR™ Study 2021-09-23 08:00
INOVIO Receives Regulatory Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800, in Mexico 2021-09-22 20:00
LSO Medical Announces CE Approval of Next-Gen LUMESEAL Laser for Treatment of Varicose Vein. 2021-09-22 03:04
Novavax to Participate in Fireside Chat at Devex @ UNGA 76 2021-09-21 04:46
RhoVac announces the completion of patient recruitment for the BRaVac clinical phase IIb study of RV001 in prostate cancer 2021-09-21 04:06
Terumo celebrates 100-year anniversary in Asia with an eye to the future 2021-09-20 10:00
Illumina reaffirms commitment to the National Project of Bio Big Data in Korea 2021-09-20 07:00
Innovent Releases Interim Analysis Results of Sintilimab plus Chemotherapy for the First-Line Treatment of Esophageal Squamous Cell Carcinoma in the Phase 3 ORIENT-15 Study at ESMO Congress 2021 2021-09-18 08:00
Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2021 2021-09-17 19:00
Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment 2021-09-17 18:30
BioVaxys Cancer Vaccine Manufacturing Partner Bio Elpida Reaches Bioproduction Milestone 2021-09-17 15:00
Innovent Releases Phase 2 Results of Pemigatinib in Chinese Patients with Advanced Cholangiocarcinoma at ESMO Congress 2021 2021-09-17 08:00
PharmaZell and Novasep enter into exclusive negotiations in new drive to create a technology-driven leader for complex small molecules and ADCs of global scale 2021-09-17 03:59
1 102 103 104 105 106 212